Delivery Order SPE2DR25D9207-SPE2DR26FHDB2
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at approximately $17,000 by the Defense Logistics Agency (DLA) on July 18, 2025. The contract, which carries no set-aside designation, covers the supply of Somatuline Depot 120 mg/0.5 ml injectable medication with an ultimate completion date of August 8, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $21,222.80 by the Defense Logistics Agency on August 11, 2025. The order covers the supply of Somatuline Depot 120 mg/0.5 ml injectable medication, with an ultimate completion date of September 2, 2025. This delivery order was issued without a set-aside designation, and the place of performance is located in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $16,978.24 by the Defense Logistics Agency (DLA) on June 25, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml injections. This firm fixed-price delivery order, which carries an ultimate completion date of July 17, 2025, represents a direct fulfillment requirement under DMS Pharmaceutical Group's existing Indefinite Delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,218.45, is for the delivery of 4564464622 ! SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a pharmaceutical product, with a period of performance through May 17, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA,...
- This is a $6,436.92 firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Somatuline 120mg pharmaceutical products, with a completion date of January 30, 2024. The contract has no set-aside designation. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of branded and generic...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $5,363.85, is for the supply of the pharmaceutical product Somatulin-Depot 60mg, with an ultimate completion date of May 6, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $12,873.80 award is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialized pharmaceutical product, with an ultimate completion date of January 2, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $21,222.80, is for the pharmaceutical product SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML. The contract is a firm fixed-price delivery order with a completion date of February 26, 2025. DMS Pharmaceutical Group Inc. has a larger Indefinite Delivery Contract (IDC) with the DLA...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-six thousand four hundred sixty-three dollars by the Defense Logistics Agency Troop Support Medical. This order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to various military treatment facilities supported by the Defense Logistics Agency. Under this particular order, DMS Pharmaceutical Group will...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program, an Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the...
- SPE2DR25D9207Indefinite Delivery Contract
- SPE2DR25D9207-SPE2DR26FHDB2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $21,274.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Somatuline Depot 120 mg/0.5 ml injections. Issued on January 22, 2026, with a completion date of February 12, 2026, this firm fixed-price delivery order carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has maintained a strong performance record as a critical supplier within the federal pharmaceutical supply chain since its SAM registration in 2001, delivering a comprehensive portfolio of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to support DoD medical operations. The PPV-G GEN V contract, awarded on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, positions the company to fulfill diverse and specialized pharmaceutical requirements across the military healthcare system. This delivery order for Somatuline Depot represents one of numerous firm fixed-price orders issued under this broader contract vehicle to meet recurring medical supply needs of military treatment facilities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.3k | 1/21/26 |